Role of Cancer Testis Antigen in Breast Cancer

BiHe XU,Yun XUE,XiaoQin CHEN,RongXin XIAO,Bin LI,XiZhao SUI,LingYu DING,YunShen JIAO,KaiLin YIN,HuanHuan LI,ZiRui GAO,Xi CHEN,LiKai GUO,QianQian WANG,JinQiu FENG,YueDan WANG,Ming CHU
DOI: https://doi.org/10.3969/j.issn.2095-6894.2017.02.001
2017-01-01
Abstract:Cancer?testis antigen is a kind of cancer antigen with highly restricted expression. It is expressed in a wide variety of malignant tumors but it?s expression in normal tissue is mostly restricted to germ cells of the testis. CTAs can elicit immune response mediated by cytotoxic T lymphocytes, while testis cells miss the attack due to the lack of MHC class 1 molecules. Breast cancer is one of the most common and death?related diseases among women. Nevertheless, the incidence of CTAs in breast cancer brings hope to the development of breast cancer therapy. In this review, we briefly described the expression of CTAs in breast cancer, and summarized the biological function of CTAs as well as the value of applying CTAs to breast cancer immunotherapy.
What problem does this paper attempt to address?